Lavipharm S.A (LAVI) — Capital Reinvestment Ratio
Lavipharm S.A (LAVI) has a Capital Reinvestment Ratio of 33.32x as of December 2022, meaning it reinvests 33% of its operating cash flow (€527.00K) in capital expenditures (€17.56 Million). Check Lavipharm S.A (LAVI) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Lavipharm S.A Capital Reinvestment Ratio (2014–2024)
This chart tracks Lavipharm S.A's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Lavipharm S.A (LAVI) cash conversion ratio.
Annual Capital Reinvestment Ratio for Lavipharm S.A (2014–2024)
Year-by-year Capital Reinvestment Ratio for Lavipharm S.A from 2014 to 2024. See cash generation quality of Lavipharm S.A to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.08x | €4.64 Million | €9.64 Million | ▼ -85.4% |
| 2023 | 14.26x | €284.00K | €4.05 Million | ▲ +34.0% |
| 2022 | 10.64x | €3.35 Million | €35.62 Million | ▲ +2020.0% |
| 2021 | 0.50x | €3.82 Million | €1.92 Million | ▼ -3.1% |
| 2020 | 0.52x | €2.85 Million | €1.48 Million | ▼ -38.0% |
| 2019 | 0.84x | €2.89 Million | €2.42 Million | ▲ +14.7% |
| 2018 | 0.73x | €1.42 Million | €1.03 Million | ▲ +215.0% |
| 2017 | 0.23x | €1.51 Million | €350.00K | ▲ +44.4% |
| 2016 | 0.16x | €606.00K | €97.00K | ▲ +300.9% |
| 2015 | 0.04x | €576.00K | €23.00K | ▼ -92.1% |
| 2014 | 0.51x | €2.38 Million | €1.20 Million | — |